The American Journal of Managed Care > April 2017
The American Journal of Managed Care - April 2017
April 27, 2017 – Jonas B. Green, MD, MPH, MSHS; Martin F. Shapiro, MD, PhD; Susan L. Ettner, PhD; Jennifer Malin, MD, PhD; Alfonso Ang, PhD; and Mitchell D. Wong, MD, PhD
Patients receiving care for advanced non—small cell lung cancer in small, independent oncology practices are more likely to receive chemotherapy in the last 30 days of life.
April 28, 2017 – Bruce Feinberg, DO
The complex interplay of behavioral economics may result in reimbursement methodology alternatives to the prevailing fee-for-service payment system having less impact on prescribing behavior than has been conjectured.
April 23, 2017 – Douglas W. Roblin, PhD; Hangsheng Liu, PhD; Lee F. Cromwell, MS; Michael Robbins, PhD; Brandi E. Robinson, MPH; David Auerbach, PhD; and Ateev Mehrotra, MD, MPH
In primary care, nurse practitioners and physician assistants do not necessarily order more ancillary services, or more costly services among alternatives, than physicians.
April 21, 2017 – Nancy D. Beaulieu, PhD; Karen E. Joynt, MD, MPH; Robert Wild, MS, MPH; and Ashish K. Jha, MD, MPH
High-cost patients are only modestly concentrated in specific hospitals and healthcare markets.
TRENDS FROM THE FIELD
The Relationship Between Adherence and Total Spending Among Medicare Beneficiaries With Type 2 Diabetes
April 19, 2017 – Joanna P. MacEwan, PhD; John J. Sheehan, PhD; Wes Yin, PhD; Jacqueline Vanderpuye-Orgle, PhD; Jeffrey Sullivan, MS; Desi Peneva, MS; Iftekhar Kalsekar, PhD; and Anne L. Peters, MD
This study describes a widespread variation in medication adherence, pharmacy cost sharing, and medical spending. Increased cost sharing may decrease adherence and increase total diabetes spending.
April 12, 2017 – Andrew S. Hwang, MD, MPH; Jeffrey M. Ashburner, PhD, MPH; Clemens S. Hong, MD, MPH; Wei He, MS; and Steven J. Atlas, MD, MPH
This study demonstrates that the predictive accuracy of primary care physicians’ assessment of future hospitalization risk is comparable to commonly used quantitative risk stratification instruments.
The Breathmobile Improves the Asthma Medication Ratio and Decreases Emergency Department Utilization
April 13, 2017 – Tricia Morphew, MSc; Wendy Altamirano, MPH, MBA; Stanley L. Bassin, EdD; and Stanley P. Galant, MD
An examination of the asthma medication ratio (â‰¥0.50) as an informative metric in program evaluation and for healthcare organizations to measure quality of care provided to patients with asthma.
April 19, 2017 – Azam Sabahi, BS; Leila Ahmadian, PhD; Moghadameh Mirzaee, PhD; and Reza Khajouei, PhD
The main reason given for receiving results online was time savings, reported by 77% of participants, followed by lowering the chance of missing the results (31%).
April 20, 2017 – Eric A. Wright, PharmD, MPH; Steven R. Steinhubl, MD; J.B. Jones, PhD, MBA; Pinky Barua, MSc, MBA; Xiaowei Yan, PhD; Ryan Van Loan, BA; Glenda Frederick, BA; Durgesh Bhandary, MS; and David Cobden, Ph
Patients endure heavy medication complexity following hospital discharge for acute coronary syndrome.
April 28, 2017 – Barak D. Richman, JD, PhD; Nick Kitzman, JD; Arnold Milstein, MD, MPH; and Kevin A. Schulman, MD
The authors propose a simple legal mechanism to combat chargemaster abuses and encourage provider price competition. This solution is superior to prevailing legislative and regulatory responses to surprise out-of-network bills.